Slides on Key Decisions in HIV Care: Choosing Initial ART in PWH With Transmitted Drug Resistance

Learn data and recommendations for initiating ART in a patient with transmitted antiretroviral drug resistance.
John D. Baxter, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 407 KB
Released: January 24, 2022


Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Related Content

Dr Christine Katlama discusses minimizing ART exposure with dual-therapy and intermittent dosing strategies, from Clinical Care Options (CCO)

person default Christine Katlama, MD Released: January 4, 2023

Expert HIV faculty analyze new data from AIDS 2022, from Clinical Care Options (CCO)

Joseph J. Eron, Jr., MD
Program Director
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Princy N. Kumar, MD, FIDSA, MACP person default Mary W. Montgomery, MD David A. Wohl, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Registered Nurses: 1.5 Nursing contact hours Pharmacists: 1.5 contact hours (0.15 CEUs) Released: December 23, 2022 Expired: December 22, 2023

Joseph Eron、Karine Lacombe、Chloe Orkin 和 Babafemi Taiwo 博士关于 IDWeek 和 HIV Glasgow 2022 的 HIV 数据的可下载幻灯片

Released: December 16, 2022

Доступные для скачивания слайды Clinical Care Options (CCO) от следующих докторов: Джозеф Эрон, Карин Лакомб, Хлоя Оркин и Бабафеми Тайво с данными о ВИЧ по итогам IDWeek и HIV Glasgow 2022

Joseph J. Eron, Jr., MD Karine Lacombe, MD, PhD Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Babafemi Taiwo, MBBS Released: December 16, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings